Navigation Links
Molnlycke Drives 'Home' the Fight Against Staph and Other MRSA Infections

New Hibistat(R) Germicidal Towelettes Offer Consumers Convenience and

Reliability In Fight Against Super Germs

NORCROSS, Ga., Sept. 20 /PRNewswire/ -- Once almost exclusively confined to hospital settings, drug-resistant staph infections, such as MRSA (methicillin-resistant Staphylococcus aureus), are increasingly finding their way right through the front doors of homes across America.

Known as community-acquired MRSA (CA-MRSA), this strain of staph infection is found in individuals who have not been hospitalized or undergone a medical procedure within the past 12 months.(1) Outbreaks of CA-MRSA have been documented for more than 20 years(2), but recent reports indicate infections from this strain of staph are on the rise. MRSA and Staphylococcus aureus, in general, are germs that live on the skin of healthy people and spread from person to person on contaminated hands, skin and surfaces. It has the potential to become serious when it enters the body through scrapes and scratches potentially leading to blood and joint infections, pneumonia, and even death.

"We're definitely hearing more reported MRSA cases in the community, especially among active, healthy, young people," said Carolyn Twomey, RN, vice president of clinical and technical affairs, Molnlycke Health Care US. "Unfortunately, the spread of this type of MRSA stems, in large part, from individuals sharing close quarters and coming in contact with contaminated objects -- conditions we often see in schools, day cares, and locker rooms. It's easy to see how MRSA is now making its way into American households."

MRSA can survive for prolonged periods of time on common objects and surfaces, increasing the chances of cross-contamination and allowing it to be easily passed on to friends and family members. For example, MRSA can live for:

- 9 weeks on a towel;

- 14 days on formica;

- 6 months on dust;

- 56 days on a mop head; and

- 9 weeks on cotton.(3)

A key to prevention of a MRSA infection is keeping hands clean to reduce the risk of cross-contamination. However, many of the products used by consumers do not contain pharmaceutical-quality, antimicrobial agents with residual activity like chlorhexidine gluconate (CHG) found in cleansers such as Hibiclens(R), according to Twomey.

Residual activity works when the antimicrobial bonds with the skin to prevent recontamination. For hand cleansers, this means the antimicrobial continues to kill germs for a period of time after washing. Alcohol is a common hand antiseptic and is extremely effective for immediate kill. However, when alcohol dries, the germ-killing action stops. The next contaminated object touched will recontaminate the hand.

And, for those instances when regular hand washing is not an option, Molnlycke offers consumers convenient Hibistat(R) Germicidal Towelettes that kill MRSA on contact and provide up to six hours of ongoing protection.

Containing CHG, Hibistat has been proven to provide fast-acting, antimicrobial protection on contact. It kills a broad spectrum of harmful organisms, continuing to fight germs much longer than soap and water or isopropyl alcohol alone. Hibistat Towelettes work without water and contain a quick-drying formula with added emollients, making them safe for frequent daily use.

"Hibistat Towelettes are perfect for today's active and mobile society," Twomey said. "They serve as a portable defense that you can carry and use when a sink and water are not readily available. They're ideal for use away from home to help keep MRSA and other germs from making it to your doorstep in the first place."

Hibistat Towelettes and Hibiclens are available in the first aid sections at chain drug stores (available in Walgreens as of August 2007) and pharmacies located in discount retailers.

About Molnlycke Health Care US, LLC

Molnlycke Health Care US, LLC, consists of two divisions - Surgical and Wound Care. Focusing on prevention of surgically-related infections for both patients and healthcare workers, the Surgical Division (formerly Regent Medical Americas, LLC) encompasses the world's leading manufacturer and supplier of powder-free surgical gloves (Biogel(R) surgical gloves); the number one supplier (by value) of skin cleanser (Hibiclens(R) and Hibistat(R) antiseptics); and BARRIER(R) protective clothing. A leader in trauma and pain management, the Wound Care Division's market dynamics are driven by an aging population, higher incidence of pressure ulcers and increased home treatment.

(1) Bell, Edward A. "Antibiotic Choices for CA-MRSA Infections."

Infectious Disease News. March 2007.

(2) Bell, Edward A. "Treatment Options Exist for CA-MRSA Infection."

Infectious Disease News. November 2005.

(3) Journal of Infection Control (2001) 49:255-261.

SOURCE Molnlycke Health Care US, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Statement by Philip Home Chairman of the RECORD Study Steering Committee and Professor of Diabetes Medicine at Newcastle University in England
2. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
3. New Drugs in Multinational Study Show Promise in Fighting Drug-Resistant HIV
4. Neuroblastoma Expert Reviews Progress and Challenges in Fighting Difficult Pediatric Cancer
5. Alzheimers Drug Shows Promise in Fighting Cancer
6. Abbott Researchers Focus on New Cutting-Edge Approaches in the Fight Against Cancer
7. Data on Telavancin and Micafungin Hold Promise of New Therapeutic Options in Fight Against Serious Infectious Disease
8. Viral Enzyme Recruited in Fight Against Ear Infection
9. RTA 402 Shown to Protect Animals Against Toxicities of Standard Cancer Treatments
10. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
11. In Vitro and In Vivo Data Show Alfacells Onocanse is Active Against Naive and Chemoresistant Neuroblastoma Cells
Post Your Comments:
(Date:11/30/2015)...  PTS Diagnostics, the U.S.-based manufacturer of point-of-care biometric ... ® systems, and PTS Detect™ cotinine systems, has ... will propel the company into the mHealth market. ... . The technology is a system that interfaces ... and tablets, and uses test strip technology already developed ...
(Date:11/30/2015)... 2015 Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... of oral drug delivery systems, announced today it has ... with Hefei Tianhui Incubator of Technologies Co., Ltd. ("HTIT") for ... in China , Hong ... The agreements were signed at the Israel Knesset (Parliament). ...
(Date:11/30/2015)... YORK , Nov. 30, 2015 Cumberland Pharmaceuticals ... will present live at on December 3, 2015. ... --> TIME: 3:15p.m. ET LINK: ... ET LINK: --> ... online event where investors are invited to ask the company ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... December 01, 2015 , ... ... to offer individual vision insurance plans on . The multi-carrier insurance ... rate and review products, allowing consumers to compare, quote and match plans to ...
(Date:11/30/2015)... ... November 30, 2015 , ... According to ... the U.S. require dental technicians to be certified or obtain continuing education. To ... the “What’s In Your Mouth?” campaign to inform dentists that the technicians they ...
(Date:11/30/2015)... CA (PRWEB) , ... November 30, 2015 , ... The ... grafts, strip harvesting and follicular unit extraction. These techniques and procedures have been in ... patients suffering from hair loss. While Dr. Parsa Mohebi, M.D. has utilized many of ...
(Date:11/30/2015)... ... November 30, 2015 , ... During the week ... to raise funds for its research, education, support, and advocacy efforts. The campaign ... funding. , The Mesothelioma Applied Research Foundation, which also goes by Meso Foundation, ...
(Date:11/30/2015)... ... November 30, 2015 , ... Cycling, running, and walking ... on extra meaning the morning of February 28, 2016. , That’s when the ... and thousands will exercise to help children and families at Joe DiMaggio Children’s ...
Breaking Medicine News(10 mins):